Posts Tagged ‘Sarepta Therapeutics Inc. (SRPT)’

Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Nektar Therapeutics (NASDAQ:NKTR)
Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment......(read more)

Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Acorda Therapeutics Inc (NASDAQ:ACOR)
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age. Although there are In excess of 8,000 hedge funds......(read more)

Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Santarus, Inc. (NASDAQ:SNTS)
What should a smart Santarus, Inc. (NASDAQ:SNTS) investor do? In the financial world, there are a multitude of gauges investors can use to watch publicly......(read more)

Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc
Is it smart to be bullish on Sarepta Therapeutics Inc (NASDAQ:SRPT)? If you were to ask many of your fellow readers, hedge funds are seen as overrated......(read more)

Sarepta Therapeutics Inc (SRPT), GlaxoSmithKline plc (ADR) (GSK): An Edge Emerges in the Race to Treat Muscular Dystrophy

Sarepta Therapeutics Inc
In a previous article, I speculated on the race to develop a Duchenne muscular dystrophy, or DMD, drug and who might win it. It seems now that Sarepta......(read more)

GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): Could This DMD Treatment Become a Blockbuster Drug?

GlaxoSmithKline plc (ADR) (NYSE:GSK)
Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene — the largest gene on the X......(read more)

ChemoCentryx Inc (CCXI), GlaxoSmithKline plc (ADR) (GSK): Horrendous Health-Care Stocks This Week

ChemoCentryx Inc (NASDAQ:CCXI)
While many investors worried about the Nasdaq’s three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn’t have......(read more)

What Hedge Funds Think About VIVUS, Inc. (VVUS)

VIVUS, Inc. (NASDAQ:VVUS)
Are you curious what the richest investors think about VIVUS, Inc. (NASDAQ:VVUS)? In the 21st century investor’s toolkit, there are dozens of metrics......(read more)

Alexion Pharmaceuticals, Inc. (ALXN), Sarepta Therapeutics Inc (SRPT), Regeneron Pharmaceuticals Inc (REGN): Is There Any Remaining Value in This Industry Leader?

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
At some point, a company reaches a level of maximum valuation. It doesn’t mean the company becomes bad, but rather all upside is priced in and future......(read more)

Sarepta Therapeutics Inc (SRPT), ISIS Pharmaceuticals, Inc. (ISIS): Is Questcor Pharmaceuticals Inc (QCOR) Still Undervalued?

Questcor Pharmaceuticals Inc (NASDAQ:QCOR)
It has been approximately a year since the Citron Research report about Questcor Pharmaceuticals Inc (NASDAQ:QCOR) came out, which caused the stock to......(read more)

GlaxoSmithKline plc (ADR) (GSK), Gilead Sciences, Inc. (GILD): Did Sarepta Therapeutics Inc (SRPT) Just Knock Out Its DMD Competitor?

Sarepta Therapeutics Inc
Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa  for a moment......(read more)

GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): The Good and Bad of a Competitor’s Failure

GlaxoSmithKline plc (ADR) (NYSE:GSK)
On the surface, GlaxoSmithKline plc (ADR) (NYSE:GSK)‘s release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc......(read more)

Mylan Inc. (MYL), YY Inc (ADR) (YY): Stocks Near 52-Week Highs Worth Selling

Mylan Inc. (NASDAQ:MYL)
Even with the broad-based S&P 500 retracing for three straight days amid worries that the Federal Reserve may begin paring back its monthly bond-buying......(read more)

Regeneron Pharmaceuticals Inc (REGN), Pharmacyclics, Inc. (PCYC): Is There Pipeline Potential in These Biotech Stocks?

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
It is not uncommon for a biotechnology company to be valued solely on the potential of one drug. For many small and midcap biotechs, the potential of......(read more)

GT Advanced Technologies Inc (GTAT), Outerwall Inc (OUTR): The Nasdaq’s 5 Most Hated Stocks

GT Advanced Technologies Inc (NASDAQ:GTAT)
Economic problems and worries? We’ll have none of those here, says the Nasdaq Composite, which soared to a fresh 12-year high on this week’......(read more)

Questcor Pharmaceuticals Inc (QCOR), Sarepta Therapeutics Inc (SRPT): Here’s What This $7 Billion Contrarian Has Been Buying

Questcor Pharmaceuticals Inc (NASDAQ:QCOR)
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)

AcelRx Pharmaceuticals Inc (ACRX): Long-Term Growth With Biotech Innovators

AcelRx Pharmaceuticals Inc
The global biotechnology industry is expected to reach $320 billion by 2015, up from $232 billion in 2012. Improving healthcare infrastructure and focus......(read more)

Sequenom, Inc. (SQNM), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week

Sequenom, Inc. (NASDAQ:SQNM)
This week’s list of the most horrendous health-care stocks is brought to you by the letter “S.” Just like on Sesame Street, all of the......(read more)

Array Biopharma Inc (ARRY), InterMune Inc (ITMN): Three Humongous Health-Care Stocks This Week

Array Biopharma Inc (NASDAQ:ARRY)
After extensive research, number-crunching, sorting, and filtering, the results are in. Here are your three most humongous performers in the world of......(read more)

Sarepta Therapeutics Inc (SRPT) Moves Ahead With Seeking Eteplirsen Approval: Hip, Hip, Uh-Oh?

Sarepta Therapeutics Inc
Investors wondered for months if Sarepta Therapeutics Inc (NASDAQ:SRPT) would pursue accelerated approval for Duchenne muscular dystrophy, or DMD, drug......(read more)

Prosensa Holding BV (RNA), WebMD Health Corp. (WBMD): Three Humongous Health-Care Stocks This Week

Prosensa
If you thought the fireworks ended after the Fourth of July celebrations last week, think again. Plenty of pops and bangs were heard in the world of health......(read more)

Sarepta Therapeutics Inc (SRPT): Is The DMD Market Becoming Too Crowded?

Sarepta Therapeutics Inc
A year ago, AVI BioPharma underwent a process from being an $85 million biotechnology company to a $1.3 billion company called Sarepta Therapeutics Inc......(read more)

YRC Worldwide, Inc. (YRCW), Sarepta Therapeutics Inc (SRPT), Christopher & Banks Corporation (CBK): Russell Rebalance Could Push These Stocks Even Higher!

YRC Worldwide, Inc. (NASDAQ:YRCW)
Last year, these three stocks weren’t even on the radar of most retail investors, but have since returned incredible gains. Now, another catalyst could......(read more)

Sarepta Therapeutics Inc (SRPT), National-Oilwell Varco, Inc. (NOV): Here’s What This $17 Billion Hedge Fund Company Has Been Buying

Sarepta Therapeutics Inc
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)

Insiders Have Bought Hess Corp. (HES), Questcor (QCOR), and More

Hess Corp. (NYSE:HES)
One implication of the principle of diversification is that company insiders- who, in a way, are already “invested” in the company as it is a source......(read more)
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 30 percentage points in 13 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!